Related Experiment Video
Updated: May 27, 2025
09:40
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
2.6K
TumorAgDB1.0: tumor neoantigen database platform.
Yan Shao1, Yang Gao2, Ling-Yu Wu1
1School of Medical Infand Engineering, Xuzhou Medical University, No. 209, Tongshan Road, Yunlong District, Xuzhou, Jiangsu 221004, China.
Database : the Journal of Biological Databases and Curation
|February 19, 2025
Summary
This study introduces TumorAgDB1.0, a comprehensive database for tumor neoantigens, addressing challenges in cancer immunotherapy. It enhances neoantigen immunogenicity prediction by integrating data and tools for researchers.
Area of Science:
- Oncology
- Immunology
- Bioinformatics
Background:
- Cancer immunotherapy, particularly neoantigen-based therapies, shows significant clinical promise.
- Accurate prediction of neoantigen immunogenicity is crucial but hindered by data scarcity and tool limitations.
Purpose of the Study:
- To address challenges in neoantigen immunogenicity prediction.
- To develop a comprehensive tumor neoantigen database (TumorAgDB1.0).
- To provide a user-friendly platform for neoantigen data access and analysis.
Main Methods:
- Collected and organized immunogenic neoantigen peptide data from public sources.
- Analyzed data to identify key features for immunogenicity prediction.
- Integrated existing prediction tools into a unified database.
Main Results:
- Developed TumorAgDB1.0, a comprehensive tumor neoantigen database.
- The database offers efficient data searching, detailed neoantigen characteristics, and immunogenicity prediction tools.
- Includes a data download function for researchers.
Conclusions:
- TumorAgDB1.0 is a valuable resource for neoantigen screening and validation in tumor immunotherapy.
- The database supports the development and improvement of neoantigen immunogenicity prediction tools.
- Provides strong support for researchers in the field.
Related Concept Videos
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
01:27Tumor Immunotherapy
463
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463